✦ LIBER ✦
A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome
✍ Scribed by Garcia-Manero, Guillermo; Gartenberg, Gary; Steensma, David P.; Schipperus, Martin R.; Breems, Dimitri A.; de Paz, Raquel; Valcárcel, David; Kranenburg, Britte; Reddy, Manjula; Komrokji, Rami S.
- Book ID
- 124064441
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 1013 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.